AHR and infection: Pharmacological inhibition of AhR using CH223191 has been shown to significantly reduce viral titers of SARS-CoV-2 and human coronavirus 229E (HCoV-229E) in vitro, coinciding with the activation of the AhR pathway during infection [22].